Search

Background Surgery is one of the main means of treating colorectal cancer. However, patients with colorectal cancer need to face many physical and psychological problems after surgery, which seriously affects patients' treatment outcomes and quality of life, so how to carry out effective postoperative management is extremely important. Objective To investigate the effectiveness of an integrated hospital-community-patient chronic disease management pathway intervention for postoperative colorectal cancer patients. Methods Based on different postoperative interventions, colorectal cancer patients were divided into a control group (n=40) and a co-management group (n=36) , with the control group implementing conventional postoperative interventions and the co-management group following a constructed integrated chronic disease pathway for co-management. Changes in laboratory indices, recurrent metastasis, death, postoperative complications, quality of life, and anxiety were compared between the two groups before and after surgery. Results Retrospectively selected 80 patients with colorectal cancer who were discharged from the Department of General Surgery at Yangpu Hospital, affiliated with Tongji University, between January 2021 and April 2022, as study subjects. At 3 and 6 months postoperatively, patients in the co-management group had lower carcinoembryonic antigen levels than patients in the control group (P0.05) , while at 6 months postoperatively, the incidence of recurrent metastases was lower in the co-management group than in the control group (5.6% vs. 22.5%, χ2=4.395, P=0.036) ; in addition, the incidence of complications was lower in the co-management group than in the control group at both 3 and 6 months postoperatively (0 vs. 16.2%, χ2=3.981, P=0.046; 5.6% vs. 25.0%, χ2=5.388, P=0.020) . However, the difference in mortality at 6 months postoperatively between the two groups was not significant (2.8% vs. 7.5%, χ2=0.165, P=0.685) . In quality of life scores at 6 months and 1 year postoperatively, the co-management group was higher than control patients (P

Differentiated thyroid carcinoma (DTC) is the most common thyroid carcinoma, with a generally favorable prognosis for most patients. At present, Surgery, 131I and thyroid stimulating hormone (TSH) suppression are the main therapeutic means among which, TSH suppression therapy plays an important role in the postoperative management of DTC patients, which has the effect of decreasing the risk of recurrence, slowing down the progression of the disease, and improving long-term survival. However, excessive TSH suppression can increase the risk of adverse events in the cardiovascular and skeletal systems. Currently, there is ongoing debate regarding the optimal target range for serum TSH suppression in patients of all types. In clinical practice, it is important to carefully balance the benefits and potential risks of TSH suppression, and to personalize the target range for serum TSH based on dynamic assessments during patient follow-up. This article aimed to discuss the intensity, benefits, and risks of TSH suppression after surgery for DTC patients, as well as the current controversies about this topic.

Copyright of Imaging Science & Photochemistry is the property of Imaging Science & Photochemistry Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of West China Journal of Stomatology is the property of Sichuan University, West China College of Stomatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: The study aims to investigate the correlation between total input for a period of 24 h and the daily physiological requirements to develop practical guidelines for postoperative infusion management of cleft patients., Methods: Sixty-three cleft lip and palate patients under three years old who underwent surgery were included in the study. The amount of liquid taken orally as well as intravenous input were recorded for a period of 24 h and compared with the daily physiological requirements. Based on the comparison results, the amount of intravenous infusion was adjusted to match the physiological requirements. Eighty-one patients under one year old were also included to evaluate the effectiveness of the adjustment. The amount of liquid taken orally and intravenous inputs were also recorded and the correlation between total input and urine output analyzed., Results: The total input of the first group of patients significantly exceeded the physiological requirements. After adjustment, the liquid intake remained at the same level, but the total intake moved closer to the physiological requirements. Statistically significant correlations were observed between liquid taken orally and intravenous intakes, and between total intake and urine formation., Conclusions: More precise management of postoperative infusion is necessary for cleft patients. For patients less than six months old, the amount of intravenous infusion should be around 60% of the physiological requirements, whereas that for patients between six months and one year should be around 75%.